SAN FRANCISCO, Sept. 02, 2016 -- Rodan & Fields, LLC (“Rodan + Fields”), a leading prestige skincare brand and community commerce innovator, today announced that it has signed a lease with Sunset Development Company for 150,000 square feet of new office space in the Bishop Ranch office park in San Ramon, California.
“Our expansion to the East Bay reflects the significant growth Rodan + Fields has been experiencing,” said Diane Dietz, President and Chief Executive Officer of Rodan + Fields. “Our new offices will enable us to continue the positive momentum as we work toward building a multi-billion-dollar prestige skincare brand.”
The San Ramon office is expected to be ready for full occupancy in March 2017. Rodan + Fields’ corporate headquarters will remain in downtown San Francisco.
About Rodan + Fields
Founded by Dr. Katie Rodan and Dr. Kathy Fields, Rodan + Fields’ dermatology-inspired skincare products and proprietary, technology-driven social enterprise platform are changing the way people engage in the skincare category, shop for products and care for their skin. In 2007, the company made the unprecedented move out of department stores and into the world of community commerce in order to realize the doctors’ vision for providing the closest alternative to a professional skincare experience outside of a medical office and, in the process, empowering entrepreneurial opportunity. Products are available through Rodan + Fields Independent Consultants and at www.rodanandfields.com.
Media Contact: Tony Plohoros 6 Degrees PR (908) 591-2839 [email protected]


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Instagram Outage Disrupts Thousands of U.S. Users
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



